Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 15.99B | 16.71B | 14.58B | 12.44B | 10.39B | 10.71B |
Gross Profit | 8.49B | 8.87B | 7.68B | 6.87B | 5.78B | 4.80B |
EBITDA | 2.47B | 3.20B | 2.81B | 2.10B | 1.44B | 1.30B |
Net Income | 686.29M | 917.23M | 646.96M | 432.65M | 128.87M | -129.34M |
Balance Sheet | ||||||
Total Assets | 14.51B | 15.40B | 14.21B | 13.28B | 12.09B | 11.01B |
Cash, Cash Equivalents and Short-Term Investments | 3.94B | 4.70B | 5.33B | 4.77B | 5.10B | 4.85B |
Total Debt | 5.83B | 5.91B | 6.10B | 5.64B | 6.23B | 5.62B |
Total Liabilities | 10.11B | 10.53B | 10.22B | 9.88B | 9.00B | 7.96B |
Stockholders Equity | 4.40B | 4.87B | 3.99B | 3.40B | 3.09B | 3.05B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -102.51M | 256.10M | 489.65M | -153.44M | 468.96M |
Operating Cash Flow | 0.00 | 2.51B | 2.54B | 2.55B | 1.59B | 1.06B |
Investing Cash Flow | 0.00 | -2.73B | -2.44B | -2.18B | -1.93B | 112.13M |
Financing Cash Flow | 0.00 | -305.46M | 347.74M | -698.28M | 528.54M | 924.20M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥5.72B | 6.31 | 2.04% | 14.58% | 41.62% | ||
73 Outperform | ¥12.70B | 10.91 | 2.64% | 7.79% | 22.67% | ||
73 Outperform | ¥8.05B | 2.69 | 1.95% | 6.45% | 269.38% | ||
62 Neutral | $16.90B | 11.24 | -7.48% | 2.95% | 1.60% | -23.76% | |
59 Neutral | ¥6.68B | 41.95 | ― | 22.75% | 79.57% |